BAM
CC icon

Brave Asset Management’s Chemours CC Stock Holding History

Brave Asset Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11
Closed – – 180
2016
Q3 		$0 Hold
11
– – ﹤0.01% 386
2016
Q2 		$0 Sell
11
-4,643
-100% -$41.4K ﹤0.01% 404
2016
Q1 		$33K Sell
4,654
-1,000
-18% -$5.03K 0.02% 254
2015
Q4 		$30K Buy
5,654
+2,000
+55% +$12.8K 0.02% 266
2015
Q3 		$24K Buy
+3,654
New +$38.2K 0.02% 274

Other funds holding CC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Brave Asset Management's CC Position: Q4 2016 in Review

Brave Asset Management sold out of Chemours (CC) in Q4 2016, closing a stake of 11 shares.

Brave Asset Management first reported a position in CC in Q3 2015 and held it in 5 quarters. The position peaked at $33K in Q1 2016. 417 funds tracked by Wall St. Rank hold CC as of Q4 2016.

  • Brave Asset Management reported no remaining Chemours position as of Q4 2016 after selling out during the quarter.
  • Brave Asset Management sold 11 Chemours shares in Q4 2016.
  • Brave Asset Management first reported a position in Chemours in Q3 2015 and held it in 5 quarters.
  • Brave Asset Management's Chemours position peaked at $33K in Q1 2016.
  • 417 funds tracked by Wall St. Rank held Chemours as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.